Exosome-mediated lncRNA SND1-IT1 from gastric cancer cells enhances malignant transformation of gastric mucosa cells via up-regulating SNAIL1

Guohua Jin, Jianguang Zhang, Tingting Cao, Bang Chen, Yu Tian, Yang ShiJournal of Translational Medicine 2022 · DOI

TL;DR

Researchers have discovered that gastric cancer cells "hijack" healthy neighboring cells by shipping out specific genetic instructions via exosomes. Specifically, the long non-coding RNA SND1-IT1 travels to healthy gastric mucosa cells, where it stabilizes the protein SNAIL1—a notorious driver of cancer progression—effectively turning healthy cells into invasive, malignant ones.

What Problem Does This Paper Address?

Gastric cancer (GC) remains a global health crisis, often diagnosed only after it has reached an advanced, difficult-to-treat stage. While we know cancer isn't just a localized clump of cells but a complex ecosystem, we are still mapping out how cancer cells communicate with their environment.

A major mystery in oncology is how primary tumor cells "corrupt" healthy neighboring cells. This paper investigates the role of exosomes—tiny, membrane-bound "delivery trucks" secreted by cells—and their cargo of long non-coding RNAs (lncRNAs) in driving the malignant transformation of the gastric mucosa.

Methods

The authors employed a multi-disciplinary approach combining bioinformatics, in vitro (cell culture) experiments, and in vivo (animal) models:

  • Bioinformatics: They used databases like GEO and UALCAN to identify lncRNAs that are overexpressed in the plasma of gastric cancer patients.
  • Exosome Isolation: Exosomes were extracted from gastric cancer cell lines (AGS) and verified using Nanoparticle Tracking Analysis (NTA) and Western blotting for specific markers (CD63, CD81).
  • Mechanism Mapping: To prove how these molecules interact, they used Dual-luciferase reporter assays (to confirm RNA binding), RNA-binding protein immunoprecipitation (RIP), and RNA pull-down assays.
  • Functional Assays: Wound healing and Transwell assays measured how "transformed" healthy cells became in terms of their ability to migrate and invade.
  • In Vivo Validation: They injected exosomes into nude mice to observe tumor growth in a living system.

Datasets

The study relied on several established genomic and proteomic resources:

  • GEO (Gene Expression Omnibus): Specifically datasets GSE153413 and GSE153414 to identify differentially expressed lncRNAs in GC patient plasma.
  • UALCAN: Used to analyze gene expression levels in stomach adenocarcinoma (STAD).
  • StarBase & BioGRID: Used to predict interactions between lncRNAs, microRNAs, and proteins.

Key Insights and Ideas

The paper reveals a sophisticated "two-pronged" molecular strategy used by the lncRNA SND1-IT1 to promote cancer:

  • The ceRNA "Sponge" Effect: SND1-IT1 acts as a "competing endogenous RNA" (ceRNA). It "sponges" up miR-1245b-5p, a microRNA that normally suppresses the expression of USP3. By soaking up this microRNA, SND1-IT1 allows USP3 levels to rise.
  • Recruiting the "Bodyguard": Beyond just sponging, SND1-IT1 recruits a protein called DDX54. Together, they bind to the messenger RNA (mRNA) of USP3, protecting it from degradation and ensuring the cell keeps producing the USP3 protein.
  • The Deubiquitination Shield: The resulting high levels of USP3 act as a deubiquitinase for SNAIL1. In healthy cells, SNAIL1 is usually tagged for destruction (ubiquitination). USP3 removes these tags, stabilizing SNAIL1 and allowing it to trigger the cellular changes necessary for cancer cells to move and invade other tissues.

Key Results

  • Exosomal Transfer: The study confirmed that SND1-IT1 is significantly enriched in GC-derived exosomes and can be successfully taken up by healthy GES-1 cells.
  • Malignant Shift: Healthy cells treated with these exosomes showed a marked increase in migration and invasion capabilities. Quantitative PCR showed a significant rise in invasion markers like MMP2 and MMP9.
  • SNAIL1 Stabilization: Western blots confirmed that while SNAIL1 mRNA levels didn't change much, the protein levels spiked because the protein was no longer being degraded.
  • Tumor Growth: In mouse models, exosomes enriched with SND1-IT1 led to significantly larger and heavier tumors compared to control groups (P < 0.01).

Limitations and Future Work

The authors acknowledge a few key hurdles:

  • Cell Line Diversity: The study primarily used one type of gastric cancer cell line (AGS). Future work needs to validate these findings across a broader range of cell lines to ensure the mechanism is universal.
  • Clinical Translation: While the results in mice are promising, the study lacks direct clinical trial data. The next step is to investigate the clinicopathological relevance—essentially seeing if SND1-IT1 levels in human patients correlate directly with disease severity and survival.
  • Therapeutic Potential: The paper opens the door for using SND1-IT1 as a biomarker for early diagnosis or as a target for "anti-exosome" therapies, but these applications remain theoretical for now.

Summary updated

Abstract

Exosome-mediated lncRNA SND1-IT1 from GC cells enhances malignant transformation of GES-1 cells via up-regulating SNAIL1.
BibTeX
@article{jin2022exosome,
  author = {Guohua Jin and Jianguang Zhang and Tingting Cao and Bang Chen and Yu Tian and Yang Shi},
  title = {{Exosome-mediated lncRNA SND1-IT1 from gastric cancer cells enhances malignant transformation of gastric mucosa cells via up-regulating SNAIL1}},
  journal = {Journal of Translational Medicine},
  year = {2022},
  doi = {10.1186/s12967-022-03306-w},
}
Figure